Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 201

Results For "EMA"

2239 News Found

Boston Scientific to acquire Baylis Medical Company for US $ 1.75 billion
Medical Device | October 06, 2021

Boston Scientific to acquire Baylis Medical Company for US $ 1.75 billion

The transaction is anticipated to close in the first quarter of 2022


DentalMonitoring launches ScanBox, an AI-powered orthodontic care device
Medical Device | October 05, 2021

DentalMonitoring launches ScanBox, an AI-powered orthodontic care device

DentalMonitoring, the company that pioneered artificial intelligence in dental and orthodontic care, has announced the launch of the ScanBox


Lilly to transfer rights of two diabetes drugs to Cipla in India
Drug Approval | October 04, 2021

Lilly to transfer rights of two diabetes drugs to Cipla in India

Lilly will continue to maintain its existing operating model for the remaining portfolio of products


Biocon launches Everolimus tablets in the US
Drug Approval | October 04, 2021

Biocon launches Everolimus tablets in the US

According to IQVIA, US sales of Everolimus (Afinitor) tablets were approximately US $ 675 million in the 12 months ending July 2021


Veeda Clinical Research files DRHP for Rs 831 crore IPO
News | October 01, 2021

Veeda Clinical Research files DRHP for Rs 831 crore IPO

The issue will consist of the issuance of fresh equity shares worth up to Rs 331.60 crore and an offer for sale (OFS) of Rs 500 crore by promoters and existing shareholders


Global Health files DRHP for over Rs 500 crore issue
News | October 01, 2021

Global Health files DRHP for over Rs 500 crore issue

Global Health operates a network of four hospitals under the Medanta brand in Gurugram, Indore, Ranchi and Lucknow. In addition, one hospital is under construction in Patna, and another is planned for development in Noida


Takeda to collaborate with JCR Pharma to commercialise next-gen Hunter Syndrome therapy
Biotech | October 01, 2021

Takeda to collaborate with JCR Pharma to commercialise next-gen Hunter Syndrome therapy

Takeda to exclusively commercialize JR-141 outside the U.S. (except Japan and certain other Asia-Pacific countries) upon regulatory approval


WHO new Essential Medicines Lists focus on diabetes and cancer
Public Health | September 30, 2021

WHO new Essential Medicines Lists focus on diabetes and cancer

The listings aim to address global health priorities, identifying the medicines that provide the greatest benefits, and which should be available and affordable for all


Fortis launches CATH LAB with 3D mapping Carto 7 machine
Hospitals | September 30, 2021

Fortis launches CATH LAB with 3D mapping Carto 7 machine

Fortis Memorial Research Institute is the only hospital in India and South Asia to acquire the machine


UFlex partners with Hoffer Plastics and Mespack to launch recyclable mono-polymer hot fill pouches
Packaging | September 30, 2021

UFlex partners with Hoffer Plastics and Mespack to launch recyclable mono-polymer hot fill pouches

These pouches, manufactured at UFlex India plant, will be exported to American markets and will be majorly used for packing edible products